Engineering biomimetic epigenetic nanoinducer improves cancer immunotherapy

• 作者: Yuliang Zhao
• 来源期刊: 中国科学：化学（英文版）
• 年，卷（期）: 2021,（12）
• 所属期刊栏目: HIGHLIGHTS
• 页码范围: 2055-2056
• 页数: 2页
• 语种: 英文

摘要

Immunotherapy such as immune checkpoint blockade (ICB)and adoptive cell transfer is a revolutionary advance in the field of cancer therapy by providing clinical benefits in long-term tumor growth control and recurrence prevention.Rapid progress is also being made in the other immunotherapeutic strategies including anticancer vaccines and cytokine sup-plementary therapies.